Cases & Deals

  • Home
  • Practices
  • Burrill Life Sciences Capital Fund, Burrill Indiana Life Sciences Capital Fund, and G. Steven Burrill complete sale of $46.3 million of Common Stock in public offering by Pharmasset

Share

Burrill Life Sciences Capital Fund, Burrill Indiana Life Sciences Capital Fund, and G. Steven Burrill complete sale of $46.3 million of Common Stock in public offering by Pharmasset

January 2011

Client(s) Burrill & Company LLC

Jones Day represented Burrill Life Sciences Capital Fund, L.P., Burrill Indiana Life Sciences Capital Fund, L.P., Delaware limited partnerships, and G. Steven Burrill, as selling stockholders, in connection with the sale of $46.3 million of Common Stock in a public offering by Pharmasset, Inc., a pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.